Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director Quarterly results Acq. announced
|
Panbela Therapeutics, Inc. (SNBP)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/10/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
07/19/2023 |
8-K
| Quarterly results |
07/10/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
06/16/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
06/02/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
05/31/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
05/08/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/04/2023 |
8-K
| Quarterly results |
04/18/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
04/18/2023 |
8-K
| Quarterly results |
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/24/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
03/16/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/16/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
03/09/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
02/14/2023 |
SC 13G/A
| Cullen Michael T. reports a 3.3% stake in Panbela Therapeutics, Inc. |
02/10/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
02/10/2023 |
8-K
| Quarterly results |
02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2023 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Regulation FD Disclosure, O... |
01/30/2023 |
SC 13G
| Lind Global Fund II LP reports a 9.9% stake in PANBELA THERAPEUTICS, INC. |
01/30/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
01/26/2023 |
S-1MEF
| Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]: |
01/26/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
|
|
|